# Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
Canonical URL: https://biopharmsignal.com/news/ALGS/aligos-therapeutics-to-announce-4th-quarter-2025-financial-results-on-march-5-2026
Ticker: ALGS
Company: Aligos Therapeutics
Source: Aligos Therapeutics
Published: 2026-02-26 13:00 EST
Original Source URL: https://investor.aligos.com
## Summary

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the Company’s

## Article Body
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the Company’s
## Recent Company News
- 2026-05-27 06:30 EST — [Aligos Therapeutics Presents Positive Data at the EASL Congress 2026](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-presents-positive-data-at-the-easl-congress-2026) — Source: Aligos Therapeutics
- 2026-05-13 06:05 EST — [Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-announces-ten-abstracts-accepted-for-presentation-at-the-easl-congress-2026) — Source: Aligos Therapeutics
- 2026-05-07 20:06 EST — [Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-reports-recent-business-progress-and-first-quarter-2026-financial-results) — Source: Aligos Therapeutics
- 2026-04-30 20:05 EST — [Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-to-announce-1st-quarter-2026-financial-results-on-may-7-2026) — Source: Aligos Therapeutics
- 2026-04-24 12:00 EST — [Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Aligos Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)